Exploring the Effectiveness of AI Generative Models for Diabetic Patients

Sponsor
Pakistan Council of Scientific and Industrial Research
Study ID
NCT05883072
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Exploring AI-Chatbot — BEHAVIORAL
    All participants will be provided access to AI-Chatbot and will be asked to enquire their daily life problems related to diabetes. They will also be asked to review the replies of the Chatbot after their interaction.

Study Details

We plan to explore the usability of Generative AI-Chatbot for Diabetic Patient

Key Dates

First listed
May 31, 2023
Start date
Jan 5, 2023
Status verified
Jun 2023
Primary completion
Dec 30, 2024
Completion
Dec 31, 2026

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Intervention
    Patients will be provided access to Chatbot to enquire their querries regarding diabetic complications.

Primary Outcome Measure

Usability of the Chatbot for diabetic patient [ Time Frame: One time ]

Central Contacts

Find similar trials

Nationwide
Type 2 diabetes trialsDiabetic retinopathy trialsEndocrinology trialsMetabolic health trialsWeight loss trialsOphthalmology trialsRetina trials

Related Studies